Market Cap (In CNY)
47.67 Billion
Revenue (In CNY)
7.96 Billion
Net Income (In CNY)
1.77 Billion
Avg. Volume
45.56 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.93-8.68
- PE
- 26.64
- EPS
- 0.28
- Beta Value
- 0.519
- ISIN
- CNE100000C31
- CUSIP
- -
- CIK
- -
- Shares
- 13539214460.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jun Xu
- Employee Count
- -
- Website
- https://www.raas-corp.com
- Ipo Date
- 2008-06-12
- Details
- Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.
More Stocks
-
FRRPF
-
300690
-
066575LG Electronics Inc.
066575
-
DNACFDeNA Co., Ltd.
DNACF
-
HGTYHagerty, Inc.
HGTY
-
DPLSDarkPulse, Inc.
DPLS
-
011930Shinsung E&G Co., Ltd.
011930
-
301021